|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Common Antibiotic Tied To Rare, Fatal Heart Effect
10/19/2005 5:10:14 PM
Erythromycin, a commonly prescribed antibiotic, can cause a potentially fatal heart rhythm abnormality, according to new research.
And the risk of this complication is even higher if erythromycin is used in combination with other medications, such as some antidepressant, antifungal and heart medications, the study found.
Researchers reporting in the Sept. 9 issue of the New England Journal of Medicine found that people taking erythromycin had double the risk of dying from sudden cardiac death than people who weren't taking any of the medications in the study.
They also found a fivefold increase in the risk of sudden cardiac death for people who were taking erythromycin and medications that inhibit CYP3A, a substance in the body that helps metabolize erythromycin. Some common CYP3A inhibitors are oral antifungal agents, antidepressants, and heart drugs known as calcium-channel blockers.
|
|
|
|
|
|
|
|
|
|
|